Leveraged Finance Community Unites to Raise Awareness and Critical Funding for Melanoma Research

Source: AP News, June 2019

The leveraged finance and private equity community came together yesterday to raise a record-breaking $2.4 million dollars in the fight again melanoma. With over 1000 attendees representing more than 100 different firms involved in the financial sector, the 8 th Annual Leveraged Finance Fights Melanoma (LFFM) event helped raise critical funds to advance research through the Melanoma Research Alliance, the world’s largest non-profit funder of melanoma research.

Held each year at the Rockefeller Center’s Summer Garden in New York City, LFFM has become a fixture of the spring social calendar for New York’s finance community. Founded by Jeff Rowbottom of PSP Investments and Brendan Dillon of UBS – both melanoma survivors – LFFM since its founding has raised more than $13 million for MRA’s lifesaving melanoma research program.

“LFFM is special because not only does it support a good cause, it’s also about us as a community coming together to support a good cause,” says LFFM Co-Founder Brendan Dillon. “It’s really developed a life of its own and people not only expect it, they look forward to it.”